|
ES2769952A1
|
|
PROCEDURE FOR THE ENANTIOMERIC CONVERSION OF CALCIPOTRIOL INTERMEDIATES AND CORRESPONDING USE
|
|
ES2718417A1
|
|
Procedure for converting 24R epimers of vitamin D precursors into the corresponding 24S isomer and procedure for obtaining calcipotriol.
|
|
ES2684414A1
|
|
Galenic composition, for oral use, comprising micronized melatonin and a zinc salt and corresponding method and use
|
|
ES2674336A1
|
|
Procedure for reducing carbonilic derivatives of vitamin d and corresponding use
|
|
ES2674130A1
|
|
Topical hydroalcoholic pharmaceutical composition for treatment of otitis externa and corresponding method and use
|
|
ES2620905A1
|
|
Procedure to reduce ketones derived from vitamin D in continuous and procedure of manufacture of calcipotriol and corresponding use
|
|
ES2620319A1
|
|
Pharmaceutical composition for typical use of salycylic acid for treatment of hyperkeratosis and corresponding method
|
|
ES2575744A1
|
|
Procedure to protect vitamin D derivatives with SO2 and corresponding use
|
|
ES2575655A1
|
|
Pharmaceutical composition, for topical use, of micronized salicylic acid at high concentration and corresponding method and use
|
|
ES2539520A1
|
|
Topical application pharmaceutical composition in the form of a micronized suspension and corresponding method and uses
|
|
ES2538880A1
|
|
A procedure to obtain 4-amino-1-isobutyl-1H-imidazo [4,5-c] quinolein
|
